Yuxi Zhao

933 total citations
37 papers, 701 citations indexed

About

Yuxi Zhao is a scholar working on Molecular Biology, Physiology and Infectious Diseases. According to data from OpenAlex, Yuxi Zhao has authored 37 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Physiology and 7 papers in Infectious Diseases. Recurrent topics in Yuxi Zhao's work include Alzheimer's disease research and treatments (7 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Autism Spectrum Disorder Research (5 papers). Yuxi Zhao is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Autism Spectrum Disorder Research (5 papers). Yuxi Zhao collaborates with scholars based in China and United States. Yuxi Zhao's co-authors include Liming Shen, Javed Iqbal, Kaoyuan Zhang, Gaofeng Zeng, Chengyun Feng, Shaohui Zong, Xukun Liu, Huajie Zhang, Zhijian Yu and Jinxin Zheng and has published in prestigious journals such as Angewandte Chemie International Edition, International Journal of Molecular Sciences and Journal of Ethnopharmacology.

In The Last Decade

Yuxi Zhao

36 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuxi Zhao China 18 295 104 95 90 83 37 701
Zi-Lin Li China 15 224 0.8× 32 0.3× 51 0.5× 75 0.8× 37 0.4× 47 636
Nicole Seifert Germany 14 308 1.0× 50 0.5× 44 0.5× 29 0.3× 84 1.0× 26 720
Yoshitaka Nakamura Japan 16 217 0.7× 32 0.3× 56 0.6× 104 1.2× 77 0.9× 69 784
Xuewei Chen China 16 389 1.3× 53 0.5× 29 0.3× 32 0.4× 73 0.9× 49 883
Hongxia Ma China 19 377 1.3× 54 0.5× 34 0.4× 101 1.1× 86 1.0× 88 1.1k
Thamer H. Albekairi Saudi Arabia 17 256 0.9× 33 0.3× 29 0.3× 43 0.5× 37 0.4× 79 712
Ji‐Won Park South Korea 23 500 1.7× 56 0.5× 39 0.4× 58 0.6× 198 2.4× 72 1.3k
Ziaur Rahman India 15 329 1.1× 43 0.4× 28 0.3× 73 0.8× 56 0.7× 44 742
Jun Ying China 20 461 1.6× 20 0.2× 46 0.5× 80 0.9× 149 1.8× 47 1.1k
Hari Cohly United States 14 266 0.9× 123 1.2× 97 1.0× 43 0.5× 77 0.9× 47 797

Countries citing papers authored by Yuxi Zhao

Since Specialization
Citations

This map shows the geographic impact of Yuxi Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxi Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxi Zhao more than expected).

Fields of papers citing papers by Yuxi Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuxi Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxi Zhao. The network helps show where Yuxi Zhao may publish in the future.

Co-authorship network of co-authors of Yuxi Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Yuxi Zhao. A scholar is included among the top collaborators of Yuxi Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuxi Zhao. Yuxi Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhao, Yuxi, Xiaoxin Wu, Xinyu Wang, & Lanjuan Li. (2025). Evolving therapeutic strategies for severe fever with thrombocytopenia syndrome: from past to future. Therapeutic Advances in Infectious Disease. 12. 2038575602–2038575602.
3.
Yin, Junling, Xueying Zheng, Yuxi Zhao, et al.. (2024). Investigating the Therapeutic Effects of Ferroptosis on Myocardial Ischemia‐Reperfusion Injury Using a Dual‐Locking Mitochondrial Targeting Strategy. Angewandte Chemie International Edition. 63(21). e202402537–e202402537. 26 indexed citations
4.
Luo, Ping, Junrui Li, Ruolan Wang, et al.. (2024). Molecular basis for the activation of PAF receptor by PAF. Cell Reports. 43(7). 114422–114422. 6 indexed citations
5.
Shen, Liming, Xiaoxiao Tang, Huajie Zhang, et al.. (2023). Targeted Metabolomic Analysis of the Eye Tissue of Triple Transgenic Alzheimer’s Disease Mice at an Early Pathological Stage. Molecular Neurobiology. 60(12). 7309–7328. 2 indexed citations
6.
Jing, Lin, Kaoyuan Zhang, Xueshan Cao, et al.. (2022). iTRAQ-Based Proteomics Analysis of Rat Cerebral Cortex Exposed to Valproic Acid before Delivery. ACS Chemical Neuroscience. 13(5). 648–663. 8 indexed citations
7.
Chen, Junwen, Jinlian Chen, Jinxin Zheng, et al.. (2022). 20S-ginsenoside Rg3 inhibits the biofilm formation and haemolytic activity of Staphylococcus aureus by inhibiting the SaeR/SaeS two-component system. Journal of Medical Microbiology. 71(10). 4 indexed citations
8.
Shen, Liming, Huajie Zhang, Lin Jing, et al.. (2022). A Combined Proteomics and Metabolomics Profiling to Investigate the Genetic Heterogeneity of Autistic Children. Molecular Neurobiology. 59(6). 3529–3545. 16 indexed citations
9.
Zheng, Jinxin, Yongpeng Shang, Yang Wu, et al.. (2022). Loratadine inhibits Staphylococcus aureus virulence and biofilm formation. iScience. 25(2). 103731–103731. 26 indexed citations
10.
Liu, Xiaoming, Yuxi Zhao, Hang Cheng, et al.. (2022). Comparison of antibacterial activities and resistance mechanisms of omadacycline and tigecycline against Enterococcus faecium. The Journal of Antibiotics. 75(8). 463–471. 4 indexed citations
11.
Bai, Bing, Yuxi Zhao, Guangjian Xu, et al.. (2022). In vitro activity of tigecycline and proteomic analysis of tigecycline adaptation strategies in clinical Enterococcus faecalis isolates from China. Journal of Global Antimicrobial Resistance. 30. 66–74. 4 indexed citations
13.
Chen, Zhong, Yuxi Zhao, Junwen Chen, et al.. (2022). In vitro activities of thiazolidione derivatives combined with daptomycin against clinical Enterococcus faecium strains. BMC Microbiology. 22(1). 16–16. 5 indexed citations
14.
Zhang, Huajie, Yuxi Zhao, Danqing Zhao, et al.. (2021). Potential biomarkers identified in plasma of patients with gestational diabetes mellitus. Metabolomics. 17(11). 99–99. 14 indexed citations
15.
Shen, Liming, Xinqian Chen, Shifeng Xiao, et al.. (2021). Proteomic Profiling of Cerebrum Mitochondria, Myelin Sheath, and Synaptosome Revealed Mitochondrial Damage and Synaptic Impairments in Association with 3 × Tg‐AD Mice Model. Cellular and Molecular Neurobiology. 42(6). 1745–1763. 18 indexed citations
16.
Zhao, Yuxi, Jinlian Chen, Bing Bai, et al.. (2020). Pathogen determination from clinical abscess fluids using metagenomic next-generation sequencing. Folia Microbiologica. 66(2). 197–202. 9 indexed citations
17.
Shen, Liming, Danqing Zhao, Youjiao Chen, et al.. (2019). Comparative Proteomics Analysis of Serum Proteins in Gestational Diabetes during Early and Middle Stages of Pregnancy. PROTEOMICS - CLINICAL APPLICATIONS. 13(5). e1800060–e1800060. 24 indexed citations
18.
Shen, Liming, Yuxi Zhao, Huajie Zhang, et al.. (2019). Advances in Biomarker Studies in Autism Spectrum Disorders. Advances in experimental medicine and biology. 1118. 207–233. 38 indexed citations
19.
Yan, Wei, Beibei Zeng, Hua Zhang, et al.. (2018). Comparative proteomic analysis of fluoride treated rat bone provides new insights into the molecular mechanisms of fluoride toxicity. Toxicology Letters. 291. 39–50. 28 indexed citations
20.
Shen, Liming, Kaoyuan Zhang, Chengyun Feng, et al.. (2017). iTRAQ‐Based Proteomic Analysis Reveals Protein Profile in Plasma from Children with Autism. PROTEOMICS - CLINICAL APPLICATIONS. 12(3). e1700085–e1700085. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026